# Exozymes Inc.: Form 8-K, filed Nov 18, 2024

- Company: [Exozymes Inc.](/companies/exoz.md) (CIK 2010788)
- Form: 8-K
- Filed: 2024-11-18
- Accepted by EDGAR: Nov 18, 2024, 16:45 ET
- Period: 2024-11-14
- Accession: 0001493152-24-046545
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/2010788/000149315224046545/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/2010788/000149315224046545/

## Items reported

- Item 1.01: Entry into a material agreement
- Item 8.01: Other events
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/2010788/000149315224046545/form8-k.htm

Filed Nov 18, 2024.
Source: SEC EDGAR, the filing index for accession 0001493152-24-046545. Last ingested by Listed: Oct 26, 2026, 15:02 ET. No prices; not investment advice.
